Filing Details

Accession Number:
0001209191-15-020496
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-02 19:20:46
Reporting Period:
2015-02-27
Filing Date:
2015-03-02
Accepted Time:
2015-03-02 19:20:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1108109 Community Health Systems Inc CYH Services-General Medical & Surgical Hospitals, Nec (8062) 133893191
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1217259 T Michael Portacci 4000 Meridian Boulevard
Franklin TN 37067
Division President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-02-27 50,000 $40.41 86,210 No 4 M Direct
Common Stock Disposition 2015-02-27 50,000 $48.56 36,210 No 4 S Direct
Common Stock Disposition 2015-02-27 3,496 $48.52 32,714 No 4 F Direct
Common Stock Acquisiton 2015-03-01 25,000 $0.00 57,714 No 4 M Direct
Common Stock Acquisiton 2015-03-01 3,333 $0.00 61,047 No 4 M Direct
Common Stock Disposition 2015-03-01 4,895 $48.52 56,152 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 F Direct
No 4 M Direct
No 4 M Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2015-02-27 50,000 $0.00 50,000 $40.41
Common Stock Performance Based Restricted Disposition 2015-03-01 25,000 $0.00 25,000 $0.00
Common Stock Performance Based Restricted Disposition 2015-03-01 3,333 $0.00 3,333 $0.00
Common Stock Performance Based Restricted Acquisiton 2015-03-01 35,000 $0.00 35,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2008-07-25 2015-07-24 No 4 M Direct
0 2015-03-01 2024-02-29 No 4 M Direct
6,667 2015-03-01 2024-02-29 No 4 M Direct
35,000 2016-03-01 2025-02-28 No 4 A Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Options (Right to Buy) $32.28 2009-02-27 2018-02-26 20,000 20,000 Direct
Common Stock Stock Options (Right to Buy) $33.90 2011-02-24 2020-02-23 10,000 10,000 Direct
Common Stock Stock Options (Right to Buy) $37.96 2012-02-23 2021-02-22 10,000 10,000 Direct
Common Stock Stock Options (Right to Buy) $21.07 2013-02-16 2022-02-15 2,667 2,667 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2018-02-26 20,000 20,000 Direct
2020-02-23 10,000 10,000 Direct
2021-02-22 10,000 10,000 Direct
2022-02-15 2,667 2,667 Direct
Footnotes
  1. The shares were sold in a series of transactions at a weighted average price of $48.5601 per share.
  2. The performance objectives governing these shares of Performance Based Restricted Stock have been met, and, accordingly, these shares will now be reported in Table 1 as directly owned shares of Restricted Stock. The restrictions lapse in 1/3 increments on the first, second and third anniversary of the date of grant.
  3. Each performance based restricted share represents a contingent right to receive one share of CYH common stock. The Company has achieved the cost savings ("synergies") from the Health Management Associates, Inc. ("HMA") merger transaction that were required to be achieved during the first year following the merger transaction, and, accordingly, 1/3 of the performance based restricted shares awarded in conjunction with the completion of the HMA merger transaction will now be reported on Table 1 as directly owned shares. The restrictions on such shares have lapsed. The remaining 2/3 of the performance based restricted shares awarded in conjunction with the completion of the HMA merger transaction will remain subject to the two-year performance target, which may be met in whole or in part in the second year following the grant. There is also a time vesting element to the maximum targets of the award. If the objectives are not met, the shares will be forfeited.